Quest Diagnostics 2004 Annual Report Download - page 6

Kenneth W. Freeman is Chairman of the Board and Chief Executive Officer of Quest Diagnostics.
Mr. Freeman joined Quest Diagnostics in May 1995 as the President and Chief Executive Officer,
was elected a director of the Company in July 1995 and was elected Chairman of the Board in
December 1996. Prior to 1995, he served in a variety of financial and managerial positions at
Corning Incorporated, which he joined in 1972. He was elected Controller and a Vice President of
Corning in 1985, Senior Vice President in 1987, General Manager of the Science Products Division
in 1989 and Executive Vice President in 1993. He was appointed President and Chief Executive
Officer of Corning Asahi Video Products Company in 1990.
William R. Grant has been Chairman of Galen Associates, a New York investment firm, since 1989.
From 1987 to 1989 he was Chairman of New York Life International and from 1979 to 1987 of
MacKay-Shields Financial Corp. He is also a former director and Vice Chairman of SmithKline
Beecham plc, and is currently a director of Advanced Medical Optics, Inc. (non-executive
Chairman), Massey Energy Co., Ocular Sciences, Inc. and Vasogen Inc (non-executive Chairman).
He has been a director of Quest Diagnostics since August 1999. Mr. Grant was designated by
SmithKline Beecham to be a director of Quest Diagnostics pursuant to the Stockholders
Agreement with SmithKline Beecham. See “Certain Relationships and Related Transactions—
Stockholders Agreement.’’
Rosanne Haggerty is the founder and Executive Director of Common Ground, a not-for-profit
housing development and management organization in New York City. Prior to founding Common
Ground in 1990, she was the coordinator of housing development at Brooklyn Catholic Charities.
Ms. Haggerty is a 2001 MacArthur Foundation Fellow. Ms. Haggerty has been a director of Quest
Diagnostics since February 2002.
Surya N. Mohapatra, Ph.D. is President and Chief Operating Officer of Quest Diagnostics. Prior to
joining Quest Diagnostics in February 1999 as Senior Vice President and Chief Operating Officer,
Dr. Mohapatra was Senior Vice President of Picker International, a worldwide leader in advanced
medical imaging technologies, where he served in various executive positions during his 18-year
tenure. Dr. Mohapatra was appointed President and Chief Operating Officer of Quest Diagnostics
in June 1999. Dr. Mohapatra is a director of Vasogen Inc. Dr. Mohapatra has been a director of
Quest Diagnostics since October 2002.
Dan C. Stanzione, Ph.D. retired from Lucent Technologies Incorporated in 2000 and is President
Emeritus of Bell Laboratories. Dr. Stanzione began his career in 1972 with Bell Laboratories,
where he led the teams working on the first microprocessors and digital signal processors. He was
appointed president of Network Systems, Lucent’s largest business unit, in 1996 and was appointed
Chief Operating Officer of Lucent in 1997. Dr. Stanzione is a director of Avaya Inc. Dr. Stanzione
has been a director of Quest Diagnostics since January 1997.
Gail R. Wilensky, Ph.D. is a Senior Fellow at Project HOPE, an international non-profit health
foundation, which she joined in 1993. From 1997 to 2001, she was the chair of the Medicare
Payment Advisory Commission, which advises Congress on all issues relating to Medicare. From
1995 to 1997 she chaired the Physician Payment Review Commission, which advised Congress on
physician payment and other Medicare issues. In 1992 and 1993, Dr. Wilensky served as a deputy
assistant to the President for policy development relating to health and welfare issues. From 1990
to 1992, she was the administrator of the Health Care Financing Administration where she
directed the Medicare and Medicaid programs. Dr. Wilensky is a director of Cephalon Inc.,
Gentiva Health Services, Inc., Manor Care Inc. and United Healthcare Corporation. Dr. Wilensky
has been a director of Quest Diagnostics since January 1997.
4?Quest Diagnostics Incorporated ?2004 Proxy Statement